Country Profile

Uruguay

Uruguay is an emerging destination for Indian pharmaceutical exports — $18.1M in FY 2025–26, with 2.0× growth over the past decade. Medicine Ingredients accounts for 59% of shipments, with vaccines contributing $1.54M. The compound annual growth rate since FY2015 stands at 6.6%.

🇺🇾 $18.1M · 2.0× growth since FY2015 · 6.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$18.1M
Exports FY2025–26 DGCIS
2.0×
Growth FY2015→2026
6.6%
CAGR FY2015→2026
59%
Medicine Ingredients Share
5
Product Categories Supplied
Uruguay is an emerging destination for Indian pharmaceutical exports — $18.1M in FY 2025–26, with 2.0× growth over the past decade. Medicine Ingredients accounts for 59% of shipments, with vaccines contributing $1.54M. The compound annual growth rate since FY2015 stands at 6.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $10.7M (58.7%) Medicines $5.54M (30.6%) Vaccines $1.54M (8.5%) Surgical & Hospital Supplies $250K (1.4%) Traditional & Herbal $154K (0.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Uruguay in the RBI overseas direct investment dataset (2011–2026).